title: Glucose-insulin-potassium infusion and mortality in the CREATE-ECLA trial.
authors.forename: Leonard A
authors.initials: LA
authors.lastname: Cobb
authors.forename: Thomas
authors.initials: T
authors.lastname: Killip
authors.forename: Costas T
authors.initials: CT
authors.lastname: Lambrew
authors.forename: Bruce A
authors.initials: BA
authors.lastname: MacLeod
authors.forename: Charles E
authors.initials: CE
authors.lastname: Rackley
authors.forename: Harry P
authors.initials: HP
authors.lastname: Selker
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Zalenski
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use; D002314:Cardioplegic Solutions / Q000627:therapeutic use*; D005947:Glucose / Q000627:therapeutic use*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007328:Insulin / Q000627:therapeutic use*; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality; D011188:Potassium / Q000627:therapeutic use*
chemical_list: D000925:Anticoagulants; D002314:Cardioplegic Solutions; D007328:Insulin; C030396:glucose-insulin-potassium cardioplegic solution; D006493:Heparin; D005947:Glucose; D011188:Potassium